Adaptimmune Therapeutics plc (MUN:473A)
Germany · Delayed Price · Currency is EUR 0.0160
0.00 (0.00%)
At close: May 21, 2026
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of €7.36 million as of August 5, 2026. Its market cap has decreased by -59.47% in one year.
Market Cap
7.36M
Enterprise Value
-2.94M
Revenue
5.05M
Ranking
n/a
PE Ratio
0.34
Stock Price
€0.02
ChartMarket Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.08B to 7.36M, a decrease of -99.32%. That is a compound annual growth rate of -35.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 6.31M | 7.56% |
| Dec 31, 2025 | 5.87M | -95.59% |
| Dec 31, 2024 | 133.14M | -18.29% |
| Dec 29, 2023 | 162.94M | -27.20% |
| Dec 30, 2022 | 223.81M | -56.55% |
| Dec 31, 2021 | 515.06M | -24.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 80.40M |
| 2invest AG | 44.63M |
| Biomark Diagnostics | 34.29M |
| Vidac Pharma Holding | 23.18M |
| co.don AG | 427.57K |
| Paion AG | 392.35K |
| bioXXmed AG | 236.52K |